Closing Keynote

Monday, March 9, 2026 4:30 PM to 5:00 PM · 30 min. (US/Pacific)

Level 5 | Palazzo L

Interoperability & HIE Forum

Executive - Organizational Strategies

Information

This session is part of the Interoperability & HIE Preconference Forum and additional registration is required.

Join Dr. Charles Jaffe, former CEO and HL7 Ambassador of HL7 International, alongside Rachel Dunscombe, the newly appointed CEO of HL7 International, for an inspiring and forward-thinking closing keynote on the future of Fast Healthcare Interoperability Resources (FHIR). Dr. Jaffe will reflect on his impactful tenure and the transformative role FHIR has played in revolutionizing global healthcare systems. He will delve into emerging trends, challenges, and opportunities that will shape the next chapter of this groundbreaking standard. This session also marks the introduction of Rachel Dunscombe, a visionary leader poised to guide HL7 International into its next era. Gain valuable insights into how FHIR will continue to drive innovation, enable seamless data exchange, and advance digital health to improve patient outcomes worldwide. Celebrate the legacy of a leader who has championed interoperability and collaboration, while looking ahead to the exciting future of healthcare transformation.

Target Audience

CEO/COOCIO/CTO/CTIO/Senior ITPayer

Level

Intermediate

Format

Visionary Perspective

CEU Type

CAHIMSCPDHTSCPHIMS

Contact Hours

0.50

Learning Objective #1

Examine the historical development and foundational principles of FHIR to understand its transformative impact on healthcare interoperability and digital health innovation

Learning Objective #2

Assess the future trajectory of FHIR by identifying advancements in technology, integration with AI and machine learning, and strategies to overcome challenges in scalability, security, and global implementation

Learning Objective #3

Develop actionable strategies for leveraging FHIR to foster collaboration among healthcare organizations, technology providers, and policymakers, ultimately driving innovation and improving patient outcomes

Session #

IHF-12